These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

783 related items for PubMed ID: 12876633

  • 1. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C, Rauch J, Kassis J, Chang ER, Joseph L, Le Comte M, Fortin PR.
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [Abstract] [Full Text] [Related]

  • 2. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P, Lehtonen KV, Javela K, Puurunen M.
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [Abstract] [Full Text] [Related]

  • 3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of high thrombotic risk triple-positive antiphospholipid syndrome patients is dependent on anti-cardiolipin and anti-β2glycoprotein I antibody detection assays.
    Chayoua W, Kelchtermans H, Moore GW, Musiał J, Wahl D, de Laat B, Devreese KMJ.
    J Thromb Haemost; 2018 Oct; 16(10):2016-2023. PubMed ID: 30079628
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
    Bizzaro N, Tonutti E, Villalta D, Tampoia M, Tozzoli R.
    Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
    [Abstract] [Full Text] [Related]

  • 9. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.
    Galli M, Luciani D, Bertolini G, Barbui T.
    Blood; 2003 Mar 01; 101(5):1827-32. PubMed ID: 12393574
    [Abstract] [Full Text] [Related]

  • 10. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, Gunnarsson I, Kastbom A, Dahlström Ö, Rönnelid J, Svenungsson E, Sjöwall C.
    Clin Exp Immunol; 2018 Oct 01; 194(1):27-38. PubMed ID: 30208508
    [Abstract] [Full Text] [Related]

  • 11. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
    Egri N, Bentow C, Rubio L, Norman GL, López-Sañudo S, Mahler M, Pérez-Isidro A, Cervera R, Viñas O, Espinosa G, Ruiz-Ortiz E.
    Front Immunol; 2021 Oct 01; 12():754469. PubMed ID: 34790198
    [Abstract] [Full Text] [Related]

  • 12. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR, Pyke S, Iannaccone L, Brancaccio V.
    Thromb Haemost; 1995 May 01; 73(5):768-73. PubMed ID: 7482401
    [Abstract] [Full Text] [Related]

  • 13. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov 01; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 14. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A, Bartlett RP, Moder KG, Chang-Miller A, Cardel LK, Heit JA, Homburger HA, Petterson TM, Christianson TJ, Nichols WL.
    Mayo Clin Proc; 2004 Apr 01; 79(4):467-75. PubMed ID: 15065611
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J, Swadzba J, Motyl A, Iwaniec T.
    J Rheumatol; 2003 Apr 01; 30(4):723-30. PubMed ID: 12672190
    [Abstract] [Full Text] [Related]

  • 16. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
    Suh-Lailam BB, Cromar A, Davis KW, Tebo AE.
    Int J Clin Exp Pathol; 2012 Apr 01; 5(3):210-5. PubMed ID: 22558475
    [Abstract] [Full Text] [Related]

  • 17. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.
    Wahl DG, Guillemin F, de Maistre E, Perret C, Lecompte T, Thibaut G.
    Lupus; 1997 Apr 01; 6(5):467-73. PubMed ID: 9229367
    [Abstract] [Full Text] [Related]

  • 18. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
    Chayoua W, Yin DM, Kelchtermans H, Moore GW, Gris JC, Musiał J, Zuily S, Ten Cate H, de Laat B, Devreese KMJ.
    Thromb Haemost; 2020 Nov 01; 120(11):1557-1568. PubMed ID: 32696448
    [Abstract] [Full Text] [Related]

  • 19. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T, Lakos G, Bhattoa HP, Shoenfeld Y, Szegedi G, Kiss E.
    Lupus; 2007 Nov 01; 16(1):39-45. PubMed ID: 17283584
    [Abstract] [Full Text] [Related]

  • 20. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
    Kassis J, Neville C, Rauch J, Busque L, Chang ER, Joseph L, Le Comte M, Subang R, Fortin PR.
    Thromb Haemost; 2004 Dec 01; 92(6):1312-9. PubMed ID: 15583739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.